CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

U66858 10mg  | ≥98%

CSNpharm

Bunaprolast is a potent inhibitor of LTB4 production in human whole blood and also exhibits significant inhibition of lipoxygenase and TXB2 release.

More Information Supplier Page

U66858 1mg  | ≥98%

CSNpharm

Bunaprolast is a potent inhibitor of LTB4 production in human whole blood and also exhibits significant inhibition of lipoxygenase and TXB2 release.

More Information Supplier Page

U66858 25mg  | ≥98%

CSNpharm

Bunaprolast is a potent inhibitor of LTB4 production in human whole blood and also exhibits significant inhibition of lipoxygenase and TXB2 release.

More Information Supplier Page

U93631 1mg  | ≥99%

CSNpharm

U93631 is a ligand of GABAA receptor ligand (IC50 = 100 nM) which can induce a rapid decay of GABA-induced chloride currents.

More Information Supplier Page

U93631 50mg  | ≥99%

CSNpharm

U93631 is a ligand of GABAA receptor ligand (IC50 = 100 nM) which can induce a rapid decay of GABA-induced chloride currents.

More Information Supplier Page

U93631 5mg  | ≥99%

CSNpharm

U93631 is a ligand of GABAA receptor ligand (IC50 = 100 nM) which can induce a rapid decay of GABA-induced chloride currents.

More Information Supplier Page

U93631 100mg  | ≥99%

CSNpharm

U93631 is a ligand of GABAA receptor ligand (IC50 = 100 nM) which can induce a rapid decay of GABA-induced chloride currents.

More Information Supplier Page

U93631 10mg  | ≥99%

CSNpharm

U93631 is a ligand of GABAA receptor ligand (IC50 = 100 nM) which can induce a rapid decay of GABA-induced chloride currents.

More Information Supplier Page

UBCS039 10mg  | ≥99%

CSNpharm

UBCS039 is a specific Sirtuin 6 activator which showed robust activating effects on Sirt6-dependent H3K18ac deacetylation of both full-length histone proteins and complete HeLa nucleosomes.

More Information Supplier Page

UBCS039 100mg  | ≥99%

CSNpharm

UBCS039 is a specific Sirtuin 6 activator which showed robust activating effects on Sirt6-dependent H3K18ac deacetylation of both full-length histone proteins and complete HeLa nucleosomes.

More Information Supplier Page

UBCS039 50mg  | ≥99%

CSNpharm

UBCS039 is a specific Sirtuin 6 activator which showed robust activating effects on Sirt6-dependent H3K18ac deacetylation of both full-length histone proteins and complete HeLa nucleosomes.

More Information Supplier Page

UBCS039 5mg  | ≥99%

CSNpharm

UBCS039 is a specific Sirtuin 6 activator which showed robust activating effects on Sirt6-dependent H3K18ac deacetylation of both full-length histone proteins and complete HeLa nucleosomes.

More Information Supplier Page

UDP disodium salt 250mg  | ≥98%

CSNpharm

UDP disodium salt is an endogenous agonist of P2Y receptor which preferentially activates P2Y6. It exhibis antagonistic effect on the P2Y14 receptor.

More Information Supplier Page

UK-14304 50mg  | ≥99%

CSNpharm

UK-14304 is an adrenergic receptor α2 agonist which can activate ERK in epicardial coronary artery culture, inhibit R-type calcium currents, as well as inhibit hormone-sensitive lipase activity and suppresses lipogenesis in adipose tissue.

More Information Supplier Page

UK-14304 5mg  | ≥99%

CSNpharm

UK-14304 is an adrenergic receptor α2 agonist which can activate ERK in epicardial coronary artery culture, inhibit R-type calcium currents, as well as inhibit hormone-sensitive lipase activity and suppresses lipogenesis in adipose tissue.

More Information Supplier Page

UK-14304 10mg  | ≥99%

CSNpharm

UK-14304 is an adrenergic receptor α2 agonist which can activate ERK in epicardial coronary artery culture, inhibit R-type calcium currents, as well as inhibit hormone-sensitive lipase activity and suppresses lipogenesis in adipose tissue.

More Information Supplier Page

UK-14304 100mg  | ≥99%

CSNpharm

UK-14304 is an adrenergic receptor α2 agonist which can activate ERK in epicardial coronary artery culture, inhibit R-type calcium currents, as well as inhibit hormone-sensitive lipase activity and suppresses lipogenesis in adipose tissue.

More Information Supplier Page

UK-371804 5mg  | ≥98%

CSNpharm

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 50mg  | ≥98%

CSNpharm

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 10mg  | ≥98%

CSNpharm

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 100mg  | ≥98%

CSNpharm

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 25mg  | ≥98%

CSNpharm

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 1mg  | ≥98%

CSNpharm

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 HCl 5mg  | ≥99%

CSNpharm

UK-371804 HCl is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 HCl 10mg  | ≥99%

CSNpharm

UK-371804 HCl is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page

UK-371804 HCl 25mg  | ≥99%

CSNpharm

UK-371804 HCl is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).

More Information Supplier Page